Success of Cytoreductive TherapyVideo Categories: Polycythemia Vera
Supported through funding from Incyte
Hear Dr. Michaelis discuss cytoreductive therapy and the risk factor for patients with hemorrhage.Supported through funding from Incyte
Drs. David Rimm and Roy Herbst discuss the challenges of reimbursement by payers and the costs to pathology department of molecular biomarker testing, especially immunohistochemistry and DNA testing.